BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olajide OA, Sarker SD. Alzheimer's disease: natural products as inhibitors of neuroinflammation. Inflammopharmacology 2020;28:1439-55. [PMID: 32930914 DOI: 10.1007/s10787-020-00751-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Wei X, Li N, Wu X, Cao G, Qiao H, Wang J, Hao R. The preventive effect of Glycyrrhiza polysaccharide on lipopolysaccharide-induced acute colitis in mice by modulating gut microbial communities. Int J Biol Macromol 2023;:124199. [PMID: 36972824 DOI: 10.1016/j.ijbiomac.2023.124199] [Reference Citation Analysis]
2 Deng M, Yan W, Gu Z, Li Y, Chen L, He B. Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer's Disease. Molecules 2023;28. [PMID: 36771152 DOI: 10.3390/molecules28031486] [Reference Citation Analysis]
3 Oliyaei N, Moosavi-Nasab M, Tanideh N, Iraji A. Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights. Brain Res Bull 2023;193:11-21. [PMID: 36435362 DOI: 10.1016/j.brainresbull.2022.11.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ogunrinade FA, Iwuanyanwu VU, Sarker SD, Olajide OA. Neuroprotection by Skimmianine in Lipopolysaccharide-Activated BV-2 Microglia. Molecules 2023;28. [PMID: 36770987 DOI: 10.3390/molecules28031317] [Reference Citation Analysis]
5 Koly HK, Sutradhar K, Rahman MS. Acetylcholinesterase inhibition of Alzheimer's disease: identification of potential phytochemicals and designing more effective derivatives to manage disease condition. J Biomol Struct Dyn 2023;:1-13. [PMID: 36651199 DOI: 10.1080/07391102.2023.2166992] [Reference Citation Analysis]
6 Soraci L, Gambuzza ME, Biscetti L, Laganà P, Lo Russo C, Buda A, Barresi G, Corsonello A, Lattanzio F, Lorello G, Filippelli G, Marino S. Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson's disease: mechanisms and therapeutic implications. J Neurol 2023;270:1346-60. [PMID: 36460875 DOI: 10.1007/s00415-022-11491-3] [Reference Citation Analysis]
7 Pandey SN, Singh G, Semwal BC, Gupta G, Alharbi KS, Almalki WH, Albratty M, Najmi A, Meraya AM. Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease. J Food Biochem 2022;46:e14426. [PMID: 36169224 DOI: 10.1111/jfbc.14426] [Reference Citation Analysis]
8 Gomaa AA, Farghaly HSM, Makboul RM, Hussien AM, Nicola MA. Polyphenols from Conyza dioscoridis (L.) ameliorate Alzheimer’s disease- like alterations through multi-targeting activities in two animal models. BMC Complement Med Ther 2022;22:288. [DOI: 10.1186/s12906-022-03765-0] [Reference Citation Analysis]
9 Katola FO, Olajide OA. Nimbolide targets multiple signalling pathways to reduce neuroinflammation in BV2 microglia.. [DOI: 10.21203/rs.3.rs-2202062/v1] [Reference Citation Analysis]
10 Yang G, Liu Y, Liu Y, Ma Y, Li Y, Chen J. Integrating network pharmacology and an experimental validation strategy elucidates the protective effect and mechanism of callicarpa nudiflora against neuroinflammation. RSC Adv 2022;12:31124-41. [PMID: 36349022 DOI: 10.1039/d2ra05143e] [Reference Citation Analysis]
11 Bepari AK, Takebayashi H, Namme JN, Rahman GMS, Reza HM. A computational study to target necroptosis via RIPK1 inhibition. J Biomol Struct Dyn 2022;:1-16. [PMID: 35938618 DOI: 10.1080/07391102.2022.2108900] [Reference Citation Analysis]
12 Chakraborty B, Mukerjee N, Maitra S, Zehravi M, Mukherjee D, Ghosh A, Massoud EES, Rahman MH, Nuzzo D. Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity 2022;2022:1-18. [DOI: 10.1155/2022/6873874] [Reference Citation Analysis]
13 Lukiw WJ. NF-kB (p50/p65)-Mediated Pro-Inflammatory microRNA (miRNA) Signaling in Alzheimer's Disease (AD). Front Mol Neurosci 2022;15:943492. [DOI: 10.3389/fnmol.2022.943492] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Olajide OA, Iwuanyanwu VU, Banjo OW, Kato A, Penkova YB, Fleet GWJ, Nash RJ. Iminosugar Amino Acid idoBR1 Reduces Inflammatory Responses in Microglia. Molecules 2022;27:3342. [PMID: 35630818 DOI: 10.3390/molecules27103342] [Reference Citation Analysis]
15 Piccialli I, Tedeschi V, Caputo L, D’errico S, Ciccone R, De Feo V, Secondo A, Pannaccione A. Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes. Front Pharmacol 2022;13:876614. [DOI: 10.3389/fphar.2022.876614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Song Z, He C, Yu W, Yang M, Li Z, Li P, Zhu X, Xiao C, Cheng S, Liu R. Baicalin Attenuated Aβ1-42-Induced Apoptosis in SH-SY5Y Cells by Inhibiting the Ras-ERK Signaling Pathway. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/9491755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Fantacuzzi M, Amoroso R, Carradori S, De Filippis B. Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Geng H, Gao D, Wang Z, Liu X, Cao Z, Xing C. Strategies for Inhibition and Disaggregation of Amyloid‐β Fibrillation. Chin J Chem 2022;40:524-38. [DOI: 10.1002/cjoc.202100646] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Verheijen MCT, Krauskopf J, Caiment F, Nazaruk M, Wen QF, van Herwijnen MHM, Hauser DA, Gajjar M, Verfaillie C, Vermeiren Y, De Deyn PP, Wittens MMJ, Sieben A, Engelborghs S, Dejonckheere W, Princen K, Griffioen G, Roggen EL, Briedé JJ. iPSC-derived cortical neurons to study sporadic Alzheimer disease: A transcriptome comparison with post-mortem brain samples. Toxicol Lett 2021;356:89-99. [PMID: 34921933 DOI: 10.1016/j.toxlet.2021.12.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Thomas C, Mayegowda Shilpa B, Babu Mythri R. Disease Modifying Potential of Functional Foods for Neurodegenerative Disorders: Status Update on Regulatory Compliance. Functional Foods - Phytochemicals and Health Promoting Potential 2021. [DOI: 10.5772/intechopen.97546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Huang R, Zhu Z, Wu Q, Bekhit AEA, Wu S, Chen M, Wang J, Ding Y. Whole-plant foods and their macromolecules: untapped approaches to modulate neuroinflammation in Alzheimer's disease. Crit Rev Food Sci Nutr 2021;:1-19. [PMID: 34553662 DOI: 10.1080/10408398.2021.1975093] [Reference Citation Analysis]
22 Ge X, Wang Y, Yu S, Cao X, Chen Y, Cheng Q, Ding F. Anti-inflammatory Activity of a Polypeptide Fraction From Achyranthes bidentate in Amyloid β Oligomers Induced Model of Alzheimer's Disease. Front Pharmacol 2021;12:716177. [PMID: 34456729 DOI: 10.3389/fphar.2021.716177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zhang M, Hu G, Shao N, Qin Y, Chen Q, Wang Y, Zhou P, Cai B. Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols. Inflammopharmacology 2021. [PMID: 34350508 DOI: 10.1007/s10787-021-00861-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Talebi M, Kakouri E, Talebi M, Tarantilis PA, Farkhondeh T, İlgün S, Pourbagher-Shahri AM, Samarghandian S. Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer's disease. Expert Rev Neurother 2021;21:625-42. [PMID: 33910446 DOI: 10.1080/14737175.2021.1923479] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
25 Kohandel Z, Farkhondeh T, Aschner M, Samarghandian S. Anti-inflammatory effects of thymoquinone and its protective effects against several diseases. Biomed Pharmacother 2021;138:111492. [PMID: 33743334 DOI: 10.1016/j.biopha.2021.111492] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
26 Welcome MO, Mastorakis NE. The taste of neuroinflammation: Molecular mechanisms linking taste sensing to neuroinflammatory responses. Pharmacol Res 2021;167:105557. [PMID: 33737243 DOI: 10.1016/j.phrs.2021.105557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 van Waarde A, Marcolini S, de Deyn PP, Dierckx RAJO. PET Agents in Dementia: An Overview. Semin Nucl Med 2021;51:196-229. [PMID: 33500121 DOI: 10.1053/j.semnuclmed.2020.12.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
28 Akawa OB, Subair TI, Soremekun OS, Olotu FA, Soliman MES. Structural alterations in the catalytic core of hSIRT2 enzyme predict therapeutic benefits of Garcinia mangostana derivatives in Alzheimer's disease: molecular dynamics simulation study. RSC Adv 2021;11:8003-18. [DOI: 10.1039/d0ra10459k] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]